Moderate riskFDA DeviceClass II

3-D Matrix PuraGel recalled for incomplete instructions for use

3-D Matrix is recalling PuraGel because its instructions for use are missing additions that FDA requested during the final review of the premarket submission. No injuries have been reported. The notice covers two sizes, 1 mL (reference 651-004) and 3 mL (reference 651-005).

From the FDA notice · Read the official notice ↗

What to do

  1. Check whether your PuraGel has lot 222-08406895 (exp. 11/03/2026) or lot 222-08586239 (exp. 12/13/2026).
  2. The notice doesn't say how to get a refund or replacement; contact 3-D Matrix, Inc. or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL);
Sold in
Nationwide
Made for
All ages (under 100 years)

Details

Units affected
230
Illnesses reported
None reported
Manufactured in
1234 Chestnut St Ste 205, Newton, Massachusetts, United States
Classification
Class II
Recall number
Z-0525-2027

In the FDA's words

Description
PuraGel; Reference Code (Volume): 1. 651-004 (1 mL), 2. 651-005 (3 mL); The instruction for use was missing additions FDA requested during the final interactive review of the premarket submission. Code: D2026OCT26 Distribution: US Nationwide distribution in the states of FL, IN, LA, NJ, SC TX. Affected quantity: 230
Hazard
The instruction for use was missing additions FDA requested during the final interactive review of the premarket submission.

Related topics